Railway Pension Investments’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
PCM
LCM
FCM
ACM
CS
Railway Pension Investments's BMY.RT Position: Q1 2020 in Review
Railway Pension Investments sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020, closing a stake of 174,800 shares — an estimated $526K sold.
Railway Pension Investments first reported a position in BMY.RT in Q4 2019 and held it in 1 quarter. The position peaked at $526K in Q4 2019. 581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.
- Railway Pension Investments reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Railway Pension Investments sold 174,800 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2020, an estimated $526K.
- Railway Pension Investments first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 1 quarter.
- Railway Pension Investments's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $526K in Q4 2019.
- 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.
Based on Railway Pension Investments's 13F filing for Q1 2020, filed 22 Apr 2020.